Latest Industry Updates
From company milestones to industry breakthroughs, uncover the stories making waves and shaping the narrative in real time.
- Featured Article
A conversation with Steve Young, member of Avoca Quality Consortium, PHUSE Working Group participant, and Tufts...
Source: Clinical Leader
- Featured Article
The pharmaceutical industry has a problem – a failure to provide women with C-suite opportunities.
...Source: International Clinical Trials
- Press Release
King of Prussia, PA – August 9, 2023: CluePoints, the premier provider of Risk-Based Study Execution...
- Featured Article
Risk-based quality management (RBQM) is used to identify and assess risks then finding ways to manage...
Source: OutsourcingPharma
- Featured Article
The ICH E6(R3) draft guideline document, currently open to public consultation, places the industry firmly in...
Source: Applied Clinical Trials
- Press Release
King of Prussia, PA – August 1, 2023: CluePoints, the premier provider of Risk-Based Quality Management...
- Featured Article
Despite the push for greater use of risk-based quality management (RBQM) in clinical research, adoption of...
Source: CenterWatch
- Featured Article
Central monitoring aims to detect emerging quality-related risks proactively during a clinical trial, resulting in study...
Source: Applied Clinical Trials
- Press Release
King of Prussia, PA – June 20, 2023: CluePoints, the premier provider of Risk-Based Study Execution...
- Featured Article
CluePoints is continuing to invest in artificial intelligence (AI) and machine learning (ML) they say they...
Source: Outsourcing Pharma
- Featured Article
With the clinical trial landscape continuing to evolve and adapt, OSP took the opportunity to speak...
Source: Outsourcing Pharma
- Press Release
King of Prussia, PA – May 3, 2023: CluePoints, the premier provider of Risk-Based Study Execution...
- Press Release
RISK MANAGEMENT SOLUTION ADDRESSES FDA, EMA, PMDA & MHRA CORONAVIRUS ADVICE King of Prussia, PA: CluePoints,...
- Press Release
King of Prussia, PA: CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Data Quality...
- Press Release
Risk Planning Guidance Addresses FDA, EMA, PMDA and MHRA Coronavirus Advice King of Prussia, PA: CluePoints,...
- Press Release
We’re delighted to announce that the recording for our COVID-19 webinar has been posted! About the...
- Press Release
Remote monitoring is mitigating the impact of SARS-CoV-2 on clinical trials, marking an acceleration in the...
- Press Release
King of Prussia, PA: CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Risk-Based Quality...
- Press Release
KING OF PRUSSIA, PA: CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Data Quality...
- Press Release
KING OF PRUSSIA, PA– FDA and its stakeholders have an interest in assuring the integrity of...
- Press Release
“I KNOW ICH E6 (R2) COMPLIANCE INSISTS ON A RISK-BASED APPROACH TO RUNNING MY TRIALS, BUT...
- Press Release
Strategic collaboration leverages CluePoints’ Central Statistical Monitoring (CSM) technology to enhance data quality and reduce operational...
- Press Release
WAYNE, PA – April 09, 2019: CluePoints, a leading provider of Risk-Based Study Execution(RBx) and Data...
- Press Release
We’re delighted to announce that registration for CluePoints’ US Risk-Based Quality Management Roadshow is now open....
- Featured Article
An essential component of risk-based quality management (RBQM), as detailed in both the ICH E8 (R1)...
Source: Applied Clinical Trials
- Featured Article
The need to boost education, shift culture, and embrace new technologies.
...Source: Applied Clinical Trials
- Featured Article
As an industry, we regularly discuss the benefits of adopting risk-based quality management (RBQM). The good...
Source: International Clinical Trials/European Pharmaceutical Contractors
- Featured Article
François Torche dispels the myth that, at least in RBQM, there is such a thing as...
Source: PM360
- Featured Article
An increase in clinical trial data is driving demand for enhanced clinical trial processes. Sponsors want...
Source: Journal for Clinical Studies
- Featured Article
Artificial intelligence (AI) is a hot topic in pharma with myriad uses such as supporting clinical...
Source: Outsourcing Pharma
- Featured Article
With increasing pressure to overcome drug development challenges and advance drugs to market faster and with...
Source: Contract Pharma
- Featured Article
Today’s drug development landscape demands contract research organizations (CROs) provide flexible models that leverage the latest...
Source: Contract Pharma
- Featured Article
In an interview with ACT editor Andy Studna at DIA 2024, Hughes, co-founder and chief commercial...
Source: Applied Clinical Trials
- Featured Article
Over the past 10 years we have seen a lot of progress in risk-based quality management...
Source: ACRP
- Featured Article
We presented an initial review of quality tolerance limit (QTL) adoption trends in the March 2023...
Source: Applied Clinical Trials
- Featured Article
Yesterday (June 5) CluePoints, providers of established statistical and AI-driven software solutions, and the Food and...
Source: Outsourcing Pharma
